The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) of the Pfizer- BioNTech’s COVID-19 vaccine for keiki ages 5-11. Pfizer’s data showed the vaccine is safe and 90 percent effective in preventing COVID-19 infections in this age group. Before vaccinations become available, the U.S. Centers for Disease Control and Prevention (CDC) will meet Nov. 2-3 to issue recommendations for clinical use of the vaccine. In preparation of this, we encourage parents and guardians to join us as we learn more about COVID-19 vaccinations for keiki and answer your questions!